| Primary |
| Hypertension |
50.0% |
| Atrial Fibrillation |
9.3% |
| Cardiac Failure |
4.1% |
| Hypertensive Heart Disease |
4.1% |
| Essential Hypertension |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Hypercholesterolaemia |
3.0% |
| Thrombosis Prophylaxis |
3.0% |
| Diabetes Mellitus |
2.6% |
| Depression |
1.9% |
| Arrhythmia |
1.5% |
| Asthma |
1.5% |
| Cardiomyopathy |
1.5% |
| Dyslipidaemia |
1.5% |
| Hyperlipidaemia |
1.5% |
| Hypothyroidism |
1.5% |
| Lung Neoplasm Malignant |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Pulmonary Embolism |
1.5% |
| Angina Pectoris |
1.1% |
|
| Renal Failure Acute |
12.1% |
| Syncope |
12.1% |
| Presyncope |
9.1% |
| Malaise |
7.6% |
| Bradycardia |
6.1% |
| Hepatotoxicity |
4.5% |
| Hypotension |
4.5% |
| Orthostatic Hypotension |
4.5% |
| Pruritus |
4.5% |
| Sinus Bradycardia |
4.5% |
| Cardiac Failure |
3.0% |
| Death |
3.0% |
| Dysphagia |
3.0% |
| Erythema |
3.0% |
| Hyperthyroidism |
3.0% |
| Hyponatraemia |
3.0% |
| International Normalised Ratio Increased |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Macular Oedema |
3.0% |
| Muscle Spasms |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
35.4% |
| Hypertension |
21.7% |
| Drug Use For Unknown Indication |
11.1% |
| Intentional Overdose |
4.3% |
| Arrhythmia |
3.8% |
| Atrial Flutter |
3.0% |
| Type 2 Diabetes Mellitus |
2.4% |
| Myocardial Ischaemia |
1.9% |
| Self Injurious Behaviour |
1.7% |
| Atrial Fibrillation |
1.4% |
| Dependence |
1.4% |
| Drug Abuse |
1.4% |
| Long Qt Syndrome |
1.4% |
| Nephrogenic Anaemia |
1.4% |
| Pain |
1.4% |
| Ventricular Arrhythmia |
1.4% |
| Cardiac Failure |
1.2% |
| Cardiac Failure Chronic |
1.2% |
| Heart Rate Abnormal |
1.2% |
| Hypercholesterolaemia |
1.2% |
|
| Loss Of Consciousness |
9.5% |
| Toxicity To Various Agents |
8.4% |
| Renal Failure Acute |
7.4% |
| Ventricular Tachycardia |
7.4% |
| Completed Suicide |
6.3% |
| Asthenia |
5.3% |
| Peripheral Coldness |
5.3% |
| Syncope |
5.3% |
| Bradycardia |
4.2% |
| Death |
4.2% |
| Hypotension |
4.2% |
| Hypothyroidism |
4.2% |
| Multiple Drug Overdose Intentional |
4.2% |
| Oedema Peripheral |
4.2% |
| Somnolence |
4.2% |
| Bone Marrow Failure |
3.2% |
| Hyperkalaemia |
3.2% |
| Muscle Spasms |
3.2% |
| Muscular Weakness |
3.2% |
| Psoriasis |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.2% |
| Hypertension |
25.7% |
| Drug Use For Unknown Indication |
8.7% |
| Type 2 Diabetes Mellitus |
4.2% |
| Atrial Fibrillation |
3.9% |
| B-cell Lymphoma |
3.3% |
| Diabetes Mellitus |
3.2% |
| Pain |
2.9% |
| Prophylaxis |
2.8% |
| Cardiac Failure |
2.6% |
| Rheumatoid Arthritis |
2.3% |
| Depression |
2.1% |
| Hypothyroidism |
1.8% |
| Coronary Artery Disease |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Osteoporosis |
1.4% |
| Non-small Cell Lung Cancer |
1.2% |
| Hyperlipidaemia |
1.0% |
| Hepatitis C |
0.9% |
|
| Rhabdomyolysis |
10.5% |
| Thrombocytopenia |
10.1% |
| Vomiting |
10.1% |
| Weight Decreased |
6.9% |
| Pyrexia |
5.9% |
| Renal Failure Acute |
5.2% |
| Syncope |
5.2% |
| Dyspnoea |
4.6% |
| Weight Increased |
4.2% |
| Nephrotic Syndrome |
3.9% |
| General Physical Health Deterioration |
3.6% |
| Nausea |
3.6% |
| Pain In Extremity |
3.6% |
| Pneumonia |
3.6% |
| Dizziness |
3.3% |
| Hyponatraemia |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Loss Of Consciousness |
3.3% |
| Asthenia |
2.9% |
| Drug Ineffective |
2.9% |
|
| Interacting |
| Hypertension |
24.6% |
| Product Used For Unknown Indication |
14.0% |
| Convulsion |
10.5% |
| Depression |
7.0% |
| Bladder Disorder |
5.3% |
| Blood Pressure Abnormal |
5.3% |
| Flushing |
5.3% |
| Heart Rate Abnormal |
5.3% |
| Ingrowing Nail |
5.3% |
| Pain |
5.3% |
| Renal Disorder |
5.3% |
| Abdominal Discomfort |
1.8% |
| Hyperlipidaemia |
1.8% |
| Hypertriglyceridaemia |
1.8% |
| Nicotine Dependence |
1.8% |
|
| Drug Interaction |
14.3% |
| Feeling Cold |
14.3% |
| Vision Blurred |
14.3% |
| Erectile Dysfunction |
7.1% |
| Headache |
7.1% |
| Hypertension |
7.1% |
| Rhabdomyolysis |
7.1% |
| Speech Disorder |
7.1% |
| Tendonitis |
7.1% |
| Torsade De Pointes |
7.1% |
| Urinary Hesitation |
7.1% |
|
